- Home
- DLB vs CORT Comparison
DLB vs CORT Comparison
Compare DLB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DLB
- CORT
- Stock Information
- Founded
- DLB 1965
- CORT 1998
- Country
- DLB United States
- CORT United States
- Employees
- DLB N/A
- CORT N/A
- Industry
- DLB Multi-Sector Companies
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- DLB Miscellaneous
- CORT Health Care
- Exchange
- DLB Nasdaq
- CORT Nasdaq
- Market Cap
- DLB 7.9B
- CORT 8.1B
- IPO Year
- DLB 2005
- CORT N/A
- Fundamental
- Price
- DLB $72.25
- CORT $71.38
- Analyst Decision
- DLB Strong Buy
- CORT Strong Buy
- Analyst Count
- DLB 4
- CORT 4
- Target Price
- DLB $101.75
- CORT $142.00
- AVG Volume (30 Days)
- DLB 378.8K
- CORT 1.4M
- Earning Date
- DLB 08-06-2025
- CORT 07-28-2025
- Dividend Yield
- DLB 1.83%
- CORT N/A
- EPS Growth
- DLB 36.08
- CORT 8.36
- EPS
- DLB 2.64
- CORT 1.14
- Revenue
- DLB $1,320,184,000.00
- CORT $685,446,000.00
- Revenue This Year
- DLB $6.38
- CORT $35.85
- Revenue Next Year
- DLB $4.65
- CORT $35.22
- P/E Ratio
- DLB $27.37
- CORT $62.48
- Revenue Growth
- DLB 4.03
- CORT 30.93
- 52 Week Low
- DLB $66.35
- CORT $28.10
- 52 Week High
- DLB $89.66
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- DLB 37.34
- CORT 48.38
- Support Level
- DLB $73.66
- CORT $69.60
- Resistance Level
- DLB $76.59
- CORT $73.13
- Average True Range (ATR)
- DLB 1.19
- CORT 3.50
- MACD
- DLB -0.24
- CORT -0.18
- Stochastic Oscillator
- DLB 4.41
- CORT 24.77
About DLB Dolby Laboratories
Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company designs and manufactures audio, imaging, accessibility, and other hardware and software solutions for the cinema, with occasional applications in the television, broadcast, and live entertainment industries. The company operates in the United States and internationally.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.